Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F F Rutten

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Health Policy (Amsterdam, Netherlands)|September 12, 2001
Analysis of costs and cost-effectiveness in multinational trialsM A Koopmanschap, K C Touw, F F Rutten
Health Policy (Amsterdam, Netherlands)|October 28, 1999
Productivity losses without absence: measurement validation and empirical evidenceW B Brouwer, M A Koopmanschap, F F Rutten
Nederlands Tijdschrift Voor Geneeskunde|August 28, 1993
[Costs and effectiveness of diagnosis and treatment of patients with dyspepsia, determined with the aid of a computer model]C K Schipper, F F Rutten, R J Loffeld
Social Science & Medicine (1982)|July 1, 1992
Economic appraisal of asthma and COPD care: a literature review 1980-1991M P Mölken, E K Van Doorslaer, F F Rutten
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
An economic model to assess the savings from a clinical application of haematopoietic growth factorsC A Uyl-de Groot, E Vellenga, F F Rutten
Transplantation|October 1, 1993
The cost-effectiveness of preservation with UW and EC solution for use in cadaveric kidney transplantation in the case of single kidney donorsF F Rutten, R J Ploeg, J McDonnell, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 13, 1993
[Cost-effectiveness analysis of human monoclonal antibody HA-1A in patients with sepsis syndrome]B A Van Hout, F F Rutten, R H Lorijn
Health Services Research|January 1, 1975
Determinants of hospital utilization in the NetherlandsJ van der Gaag, F F Rutten, B M van Praag
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Peripheral blood progenitor cell transplantation mobilised by r-metHuG-CSF (filgrastim); a less costly alternative to autologous bone marrow transplantationC A Uyl-de Groot, D J Richel, F F Rutten
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Economic evaluation alongside cancer trials: methodological and practical aspectsG J Bonsel, F F Rutten, C A Uyl-de Groot
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Health Policy (Amsterdam, Netherlands)|September 12, 2001
Analysis of costs and cost-effectiveness in multinational trialsM A Koopmanschap, K C Touw, F F Rutten
Health Policy (Amsterdam, Netherlands)|October 28, 1999
Productivity losses without absence: measurement validation and empirical evidenceW B Brouwer, M A Koopmanschap, F F Rutten
Nederlands Tijdschrift Voor Geneeskunde|August 28, 1993
[Costs and effectiveness of diagnosis and treatment of patients with dyspepsia, determined with the aid of a computer model]C K Schipper, F F Rutten, R J Loffeld
Social Science & Medicine (1982)|July 1, 1992
Economic appraisal of asthma and COPD care: a literature review 1980-1991M P Mölken, E K Van Doorslaer, F F Rutten
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
An economic model to assess the savings from a clinical application of haematopoietic growth factorsC A Uyl-de Groot, E Vellenga, F F Rutten
Transplantation|October 1, 1993
The cost-effectiveness of preservation with UW and EC solution for use in cadaveric kidney transplantation in the case of single kidney donorsF F Rutten, R J Ploeg, J McDonnell, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 13, 1993
[Cost-effectiveness analysis of human monoclonal antibody HA-1A in patients with sepsis syndrome]B A Van Hout, F F Rutten, R H Lorijn
Health Services Research|January 1, 1975
Determinants of hospital utilization in the NetherlandsJ van der Gaag, F F Rutten, B M van Praag
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Peripheral blood progenitor cell transplantation mobilised by r-metHuG-CSF (filgrastim); a less costly alternative to autologous bone marrow transplantationC A Uyl-de Groot, D J Richel, F F Rutten
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Economic evaluation alongside cancer trials: methodological and practical aspectsG J Bonsel, F F Rutten, C A Uyl-de Groot
Pageof 9